nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—Localized exfoliation—Bleomycin—lymphatic system cancer	0.0539	0.0539	CcSEcCtD
Trisalicylate-choline—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.0244	0.0244	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Fludarabine—lymphatic system cancer	0.0216	0.0216	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Fludarabine—lymphatic system cancer	0.0208	0.0208	CcSEcCtD
Trisalicylate-choline—Burning sensation—Carmustine—lymphatic system cancer	0.0182	0.0182	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Fludarabine—lymphatic system cancer	0.0181	0.0181	CcSEcCtD
Trisalicylate-choline—Stupor—Carmustine—lymphatic system cancer	0.017	0.017	CcSEcCtD
Trisalicylate-choline—Deafness—Fludarabine—lymphatic system cancer	0.0161	0.0161	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Trisalicylate-choline—Tinnitus—Mechlorethamine—lymphatic system cancer	0.0143	0.0143	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Bleomycin—lymphatic system cancer	0.0138	0.0138	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Mitoxantrone—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Carmustine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Carmustine—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Trisalicylate-choline—Sweating—Teniposide—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Trisalicylate-choline—Flushing—Teniposide—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Trisalicylate-choline—Epistaxis—Fludarabine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Trisalicylate-choline—Anorexia—Mechlorethamine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Trisalicylate-choline—Deafness—Vincristine—lymphatic system cancer	0.00981	0.00981	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00947	0.00947	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00939	0.00939	CcSEcCtD
Trisalicylate-choline—Burning sensation—Methotrexate—lymphatic system cancer	0.00844	0.00844	CcSEcCtD
Trisalicylate-choline—Confusional state—Teniposide—lymphatic system cancer	0.0081	0.0081	CcSEcCtD
Trisalicylate-choline—Oedema—Teniposide—lymphatic system cancer	0.00803	0.00803	CcSEcCtD
Trisalicylate-choline—Stupor—Methotrexate—lymphatic system cancer	0.00785	0.00785	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.0078	0.0078	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00776	0.00776	CcSEcCtD
Trisalicylate-choline—Pruritus—Mechlorethamine—lymphatic system cancer	0.00771	0.00771	CcSEcCtD
Trisalicylate-choline—Anorexia—Teniposide—lymphatic system cancer	0.00765	0.00765	CcSEcCtD
Trisalicylate-choline—Hypotension—Teniposide—lymphatic system cancer	0.0075	0.0075	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00745	0.00745	CcSEcCtD
Trisalicylate-choline—Confusional state—Fludarabine—lymphatic system cancer	0.00712	0.00712	CcSEcCtD
Trisalicylate-choline—Oedema—Fludarabine—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Teniposide—lymphatic system cancer	0.00698	0.00698	CcSEcCtD
Trisalicylate-choline—Vomiting—Mechlorethamine—lymphatic system cancer	0.00693	0.00693	CcSEcCtD
Trisalicylate-choline—Rash—Mechlorethamine—lymphatic system cancer	0.00687	0.00687	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00682	0.00682	CcSEcCtD
Trisalicylate-choline—Flushing—Bleomycin—lymphatic system cancer	0.00676	0.00676	CcSEcCtD
Trisalicylate-choline—Anorexia—Fludarabine—lymphatic system cancer	0.00673	0.00673	CcSEcCtD
Trisalicylate-choline—Weight increased—Mitoxantrone—lymphatic system cancer	0.00672	0.00672	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Teniposide—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Trisalicylate-choline—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00658	0.00658	CcSEcCtD
Trisalicylate-choline—Sweating—Vincristine—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Trisalicylate-choline—Nausea—Mechlorethamine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Trisalicylate-choline—Urticaria—Teniposide—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Trisalicylate-choline—Erythema—Bleomycin—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Trisalicylate-choline—Hallucination—Carmustine—lymphatic system cancer	0.00633	0.00633	CcSEcCtD
Trisalicylate-choline—Sweating—Mitoxantrone—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Fludarabine—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Fludarabine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Trisalicylate-choline—Hallucination—Vincristine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Trisalicylate-choline—Constipation—Fludarabine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Trisalicylate-choline—Pain—Fludarabine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Trisalicylate-choline—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00591	0.00591	CcSEcCtD
Trisalicylate-choline—Flushing—Carmustine—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Trisalicylate-choline—Pruritus—Teniposide—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00566	0.00566	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Methotrexate—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Trisalicylate-choline—Erythema—Carmustine—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Teniposide—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Methotrexate—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Trisalicylate-choline—Confusional state—Bleomycin—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Trisalicylate-choline—Oedema—Bleomycin—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Trisalicylate-choline—Erythema—Mitoxantrone—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Trisalicylate-choline—Vomiting—Teniposide—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Trisalicylate-choline—Rash—Teniposide—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Trisalicylate-choline—Dermatitis—Teniposide—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00504	0.00504	CcSEcCtD
Trisalicylate-choline—Headache—Teniposide—lymphatic system cancer	0.00503	0.00503	CcSEcCtD
Trisalicylate-choline—Pruritus—Fludarabine—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Trisalicylate-choline—Anorexia—Bleomycin—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Trisalicylate-choline—Hypotension—Bleomycin—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Fludarabine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Trisalicylate-choline—Nausea—Teniposide—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Trisalicylate-choline—Confusional state—Carmustine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Trisalicylate-choline—Oedema—Carmustine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Bleomycin—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Trisalicylate-choline—Vomiting—Fludarabine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Trisalicylate-choline—Rash—Fludarabine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Trisalicylate-choline—Dermatitis—Fludarabine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Trisalicylate-choline—Pain—Bleomycin—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Trisalicylate-choline—Headache—Fludarabine—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Trisalicylate-choline—Lethargy—Methotrexate—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Trisalicylate-choline—Oedema—Vincristine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Trisalicylate-choline—Anorexia—Carmustine—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Trisalicylate-choline—Confusional state—Mitoxantrone—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Trisalicylate-choline—Hypotension—Carmustine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Trisalicylate-choline—Oedema—Mitoxantrone—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Trisalicylate-choline—Nausea—Fludarabine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Trisalicylate-choline—Shock—Mitoxantrone—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Trisalicylate-choline—Urticaria—Bleomycin—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Trisalicylate-choline—Anorexia—Vincristine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Trisalicylate-choline—Hypotension—Vincristine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Trisalicylate-choline—Somnolence—Carmustine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Trisalicylate-choline—Anorexia—Mitoxantrone—lymphatic system cancer	0.004	0.004	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Trisalicylate-choline—Hypotension—Mitoxantrone—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Trisalicylate-choline—Constipation—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Trisalicylate-choline—Pain—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Vincristine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Trisalicylate-choline—Somnolence—Mitoxantrone—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Carmustine—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Trisalicylate-choline—Pain—Vincristine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Trisalicylate-choline—Constipation—Vincristine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Trisalicylate-choline—Asthma—Methotrexate—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Trisalicylate-choline—Pruritus—Bleomycin—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Trisalicylate-choline—Pain—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Trisalicylate-choline—Constipation—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Trisalicylate-choline—Urticaria—Mitoxantrone—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Trisalicylate-choline—Vomiting—Bleomycin—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Trisalicylate-choline—Drowsiness—Methotrexate—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Trisalicylate-choline—Rash—Bleomycin—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Trisalicylate-choline—Dermatitis—Bleomycin—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Trisalicylate-choline—Sweating—Methotrexate—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Trisalicylate-choline—Epistaxis—Methotrexate—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Carmustine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Trisalicylate-choline—Nausea—Bleomycin—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Trisalicylate-choline—Dizziness—Carmustine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vincristine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Trisalicylate-choline—Hepatitis—Methotrexate—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Trisalicylate-choline—Vomiting—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Trisalicylate-choline—Dizziness—Vincristine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Trisalicylate-choline—Rash—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Trisalicylate-choline—Dermatitis—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Trisalicylate-choline—Headache—Carmustine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Trisalicylate-choline—Tinnitus—Methotrexate—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Trisalicylate-choline—Vomiting—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Trisalicylate-choline—Rash—Vincristine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vincristine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Trisalicylate-choline—Headache—Vincristine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Trisalicylate-choline—Nausea—Carmustine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Trisalicylate-choline—Vomiting—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Trisalicylate-choline—Rash—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Trisalicylate-choline—Headache—Mitoxantrone—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Trisalicylate-choline—Erythema—Methotrexate—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Trisalicylate-choline—Nausea—Vincristine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Methotrexate—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Trisalicylate-choline—Nausea—Mitoxantrone—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Trisalicylate-choline—Confusional state—Methotrexate—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Trisalicylate-choline—Anorexia—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Trisalicylate-choline—Hypotension—Methotrexate—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Trisalicylate-choline—Somnolence—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Trisalicylate-choline—Pain—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Trisalicylate-choline—Urticaria—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Trisalicylate-choline—Pruritus—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Trisalicylate-choline—Dizziness—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Trisalicylate-choline—Vomiting—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Trisalicylate-choline—Rash—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Trisalicylate-choline—Dermatitis—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Trisalicylate-choline—Headache—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Trisalicylate-choline—Nausea—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
